Clinical Trial Update: Study Evaluating the Safety of Lecozotan SR in Healthy Young and Elderly Subjects [Phase 1]

View source ↗

Summary

Completed Phase 1 study evaluating the safety of Lecozotan SR in healthy young and elderly subjects; sponsored by Wyeth, now a Pfizer subsidiary.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• Lecozotan SR (lecozotan SR)

Snippet

Sponsor: Wyeth is now a wholly owned subsidiary of Pfizer | Conditions: Alzheimer Disease | Phase 1 | Status: COMPLETED